Clinical modeling of T cell vaccination against autoimmune diseases in rats. Selection of antigen-specific T cells using a mitogen.
Open Access
- 30 April 1990
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 85 (5), 1594-1598
- https://doi.org/10.1172/jci114610
Abstract
Effective T cell vaccination against experimental autoimmune diseases involves treatment with activated, autoimmune T lymphocytes. The present study was undertaken to learn whether antigen-specific T cells present in low frequency could be selected in vitro without using the specific antigen. The rat models of adjuvant arthritis and experimental autoimmune encephalomyelitis were investigated using proliferation assays and limiting dilution techniques to quantify the changes in reactivity of a heterogenous population of lymphocytes to the relevant antigen. Stimulation with concanavalin A for 2 d and then culture in IL-2-containing medium led to a substantial increase in the activity and frequency of the specific autoimmune T cells. Enrichment of antigen-specific T cells could be demonstrated using lymph node, spleen, or peripheral blood lymphocytes, from rats late in the course of disease. The effect was not evident in lymphocytes from the thymus. These results are relevant to the clinical application of T cell vaccination and to investigation of self-antigens in autoimmune disease.This publication has 18 references indexed in Scilit:
- Rapid response to Con A by CD4+CD45R− rat memory lymphocytes as compared to CD4+CD45R+ lymphocytesCellular Immunology, 1989
- T-cell vaccinationImmunology Today, 1988
- Differential activation requirements for virgin and memory T cells.The Journal of Immunology, 1988
- The Self, the World and AutoimmunityScientific American, 1988
- Isolation of T cell line capable of protecting mice against collagen-induced arthritis.The Journal of Immunology, 1988
- Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure.Proceedings of the National Academy of Sciences, 1987
- “In vivo” activated splenic T cells are refractory to interleukin 2 growth “in vitro”European Journal of Immunology, 1987
- IL 2 production by mitogen-stimulated T cell subsets: helper-precursors are predominantly Lyt-2-.The Journal of Immunology, 1983
- Transient expression of interleukin 2 receptors. Consequences for T cell growth.The Journal of Experimental Medicine, 1983
- Basic encephalitogenic protein: A simplified purification on sulphoethyl‐sephadexFEBS Letters, 1970